InVivo Biosystems Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
62
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3M
- Investors
-
15
InVivo Biosystems General Information
Description
Developer of a genome editing platform designed to accelerate deep in-vivo insights into human biology. The company's platform creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies, enabling researchers to perform mutant phenotyping, drug screening and toxicological assessment.
Contact Information
Website
www.invivobiosystems.comCorporate Office
- 1505 Westec Drive
- Eugene, OR 97402
- United States
Corporate Office
- 1505 Westec Drive
- Eugene, OR 97402
- United States
InVivo Biosystems Timeline
InVivo Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 03-Jan-2024 | $3M | Completed | Generating Revenue | ||
| 10. Later Stage VC | 01-Apr-2023 | Completed | Generating Revenue | |||
| 9. Grant | 10-Dec-2020 | Completed | Generating Revenue | |||
| 8. Grant | 24-Apr-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 27-Feb-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 08-Mar-2017 | Completed | Generating Revenue | |||
| 4. Angel (individual) | 28-Aug-2015 | Completed | Startup | |||
| 3. Accelerator/Incubator | 04-Feb-2015 | Completed | Startup | |||
| 2. Grant | 01-Feb-2014 | $346K | Completed | Startup |
InVivo Biosystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
InVivo Biosystems Comparisons
Industry
Financing
Details
InVivo Biosystems Competitors (19)
One of InVivo Biosystems’s 19 competitors is BioBlocks, a Corporate Backed or Acquired company based in Hamilton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioBlocks | Corporate Backed or Acquired | Hamilton, NJ | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | ||||
| Creative Diagnostics | Corporation | Shirley, NY | ||||
| AmplifyBio | Venture Capital-Backed | West Jefferson, OH |
InVivo Biosystems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
InVivo Biosystems Patents
InVivo Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3162691-A1 | Model organisms humanized for drug discovery and screening | Pending | 21-Dec-2019 | ||
| EP-4078179-A1 | Model organisms humanized for drug discovery and screening | Pending | 21-Dec-2019 | ||
| US-20230200362-A1 | Model organisms humanized for drug discovery and screening | Pending | 21-Dec-2019 | ||
| EP-4078179-A4 | Model organisms humanized for drug discovery and screening | Pending | 21-Dec-2019 | ||
| US-20220375609-A1 | Clinical variant classifier models, machine learning systems and methods of use | Pending | 16-Oct-2019 | C12N15/90 |
InVivo Biosystems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
InVivo Biosystems Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ideaship | Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| The National Human Genome Research Institute | Government | |||
| Oregon Nano and Micro technology Institute (ONAMI) | Corporation | Minority | ||
| Oregon Venture Fund | Venture Capital | Minority |
InVivo Biosystems Acquisitions (1)
InVivo Biosystems’s most recent deal was a Merger/Acquisition with Knudra Transgenics. The deal was made on 14-Nov-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Knudra Transgenics | 14-Nov-2017 | Merger/Acquisition | Biotechnology |
InVivo Biosystems FAQs
-
When was InVivo Biosystems founded?
InVivo Biosystems was founded in 2010.
-
Where is InVivo Biosystems headquartered?
InVivo Biosystems is headquartered in Eugene, OR.
-
What is the size of InVivo Biosystems?
InVivo Biosystems has 62 total employees.
-
What industry is InVivo Biosystems in?
InVivo Biosystems’s primary industry is Biotechnology.
-
Is InVivo Biosystems a private or public company?
InVivo Biosystems is a Private company.
-
What is InVivo Biosystems’s current revenue?
The current revenue for InVivo Biosystems is .
-
How much funding has InVivo Biosystems raised over time?
InVivo Biosystems has raised $12.2M.
-
Who are InVivo Biosystems’s investors?
Ideaship, National Institutes of Health, The National Human Genome Research Institute, Oregon Nano and Micro technology Institute (ONAMI), and Oregon Venture Fund are 5 of 15 investors who have invested in InVivo Biosystems.
-
Who are InVivo Biosystems’s competitors?
BioBlocks, BioLegend, Sygnature Discovery, Creative Diagnostics, and AmplifyBio are some of the 19 competitors of InVivo Biosystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
